HomeCompareSTSEY vs ORCC

STSEY vs ORCC: Dividend Comparison 2026

STSEY yields 2.55% · ORCC yields 9.79%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ORCC wins by $1.3K in total portfolio value
10 years
STSEY
STSEY
● Live price
2.55%
Share price
$5.51
Annual div
$0.14
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.1K
Annual income
$0.25
Full STSEY calculator →
ORCC
ORCC
● Live price
9.79%
Share price
$13.48
Annual div
$1.32
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$21.4K
Annual income
$1.04
Full ORCC calculator →

Portfolio growth — STSEY vs ORCC

📍 ORCC pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSTSEYORCC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, STSEY + ORCC cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
STSEY pays
ORCC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

STSEY
Annual income on $10K today (after 15% tax)
$217.05/yr
After 10yr DRIP, annual income (after tax)
$0.21/yr
ORCC
Annual income on $10K today (after 15% tax)
$832.34/yr
After 10yr DRIP, annual income (after tax)
$0.88/yr
At 15% tax rate, ORCC beats the other by $0.67/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of STSEY + ORCC for your $10,000?

STSEY: 50%ORCC: 50%
100% ORCC50/50100% STSEY
Portfolio after 10yr
$20.8K
Annual income
$0.65/yr
Blended yield
0.00%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ORCC right now

STSEY
No analyst data
Altman Z
5.8
Piotroski
7/9
ORCC
Analyst Ratings
9
Buy
4
Hold
1
Sell
Consensus: Buy
Price Target
$16.00
+18.7% upside vs current
Range: $16.00 — $16.00
Altman Z
0.5
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

STSEY buys
0
ORCC buys
0
No recent congressional trades found for STSEY or ORCC in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSTSEYORCC
Forward yield2.55%9.79%
Annual dividend / share$0.14$1.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-50%-50%
Portfolio after 10y$20.1K$21.4K
Annual income after 10y$0.25$1.04
Total dividends collected$257.00$1.0K
Payment frequencyquarterlyquarterly
SectorStockBDC

Year-by-year: STSEY vs ORCC ($10,000, DRIP)

YearSTSEY PortfolioSTSEY Income/yrORCC PortfolioORCC Income/yrGap
1← crossover$10,828$127.68$11,190$489.61$362.00ORCC
2$11,650$64.60$12,229$256.01$579.00ORCC
3$12,498$32.48$13,216$130.74$718.00ORCC
4$13,389$16.28$14,207$66.02$818.00ORCC
5$14,335$8.15$15,234$33.17$899.00ORCC
6$15,342$4.08$16,317$16.62$975.00ORCC
7$16,418$2.04$17,468$8.32$1.1KORCC
8$17,569$1.02$18,695$4.16$1.1KORCC
9$18,799$0.51$20,006$2.08$1.2KORCC
10$20,115$0.25$21,407$1.04$1.3KORCC

STSEY vs ORCC: Complete Analysis 2026

STSEYStock

Stratec SE, together with its subsidiaries, designs and manufactures automation and instrumentation solutions in the fields of in-vitro diagnostics and life sciences in Germany, European Union, and internationally. It operates through three segments: Instrumentation, Diatron, and Smart Consumables. The Instrumentation segment designs and manufactures automated analyzer systems, including service parts and consumables for clinical diagnostics and biotechnology customers. The Diatron segment offers systems, system components, consumables, and tests for the low throughput hematology and clinical chemistry applications. The Smart Consumables segment develops and manufactures smart consumables in the fields of diagnostics, life sciences, and medical technologies. The company was formerly known as STRATEC Biomedical AG and changed its name to Stratec SE in December 2018. Stratec SE was founded in 1979 and is headquartered in Birkenfeld, Germany.

Full STSEY Calculator →

ORCCBDC

Owl Rock Capital Corporation is a business development company. The fund makes investments in senior secured or unsecured loans, subordinated loans or mezzanine loans and also considers equity-related securities including warrants and preferred stocks also pursues preferred equity investments and common equity investments. Within private equity, it seeks to invest in growth, acquisitions, market or product expansion, refinancings and recapitalizations. It seeks to invest in middle market companies based in the United States, with EBITDA between $10 million and $250 million annually and/or annual revenue of $50 million and $2.5 billion at the time of investment.

Full ORCC Calculator →
📬

Get this STSEY vs ORCC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

STSEY vs SCHDSTSEY vs JEPISTSEY vs OSTSEY vs KOSTSEY vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.